Open Source Medicine Foundation
Home / NTD Intelligence / Chikungunya

Chikungunya

Neglected tropical disease intelligence: burden, top therapeutic hits, and documented post-infectious syndrome with literature persistence rates. Pathogen: virus.

Deaths / year
200
GBD (indicative unless refreshed)
DALYs / year
300,000
GBD
Pathogen
Virus
Post-infectious
Post-infectious syndrome
Persistent symptoms
~40%
symptomatic cases

Post-infectious syndrome & persistent symptoms

Documented post-infectious syndrome
Chronic chikungunya arthritis / chronic inflammatory rheumatism
~40%
persistent symptoms — of symptomatic cases
Summary
Persistent arthralgia >=3 months in a pooled ~40% (95% CI 31-49%); cohort range 7-79%; Americas meta-analyses up to 52%.
Timeframe
months to years post-acute
Evidence strength
strong (multiple meta-analyses)
Classification
Post-infectious syndrome
Sources: Rodriguez-Morales 2016 (pooled 40%); Bonifay 2024 Lancet Infect Dis; Paixao 2018 (43% >3 mo); Webb 2024 PLoS Negl Trop Dis (44% chronic)

Top therapeutic hits

Drug / agentTypeMax phaseMechanismApproved
No drugs resolved (run live pipeline / cross-check WHO EML & DNDi).

Top associated targets: —

Burden: GBD (indicative seed unless refreshed) · Therapeutics: Open Targets / ChEMBL · Post-infectious data: curated from peer-reviewed literature (see sources above) · Ontology: EFO_0007200 · Updated 2026-07-09
Open Source Medicine Foundation · research.opensourcemed.info · Associations, not a diagnostic test.